Abstract
MB represents the most common malignant brain tumor in childhood; patients event-free survival could reach 70%, however, they still suffer from side effects of treatment. The embryonic characteristics of MB suggest that the identification of altered molecular mechanisms in the developmental pathways of the cerebellum could reduce the adverse consequences of therapy. Genes related to devel…